KLISBIO
KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-human study on nerve repair that is ongoing at the University of Zurich, Switzerland
KLISBIO
Industry:
Biotechnology Health Care Life Science Medical Device
Founded:
2014-07-31
Address:
Lomazzo, Lombardia, Italy
Country:
Italy
Website Url:
http://www.klis.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.56 M EUR
Technology used in webpage:
SPF Google Apps For Business BlueHost BlueHost DNS BlueHost Mail
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Amwise Diagnostic
Amwise Diagnostic is a leader in precision medicine technology for cancer.
Morphodyne
Morphodyne is an unique 3D bioprinting technology platform.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Employees Featured
Founder
Investors List
Principia SGR
Principia SGR investment in Convertible Note - KLISBio
Principia SGR
Principia SGR investment in Series A - KLISBio
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - KLISBio
Official Site Inspections
http://www.klis.bio
- Host name: cluster-a.redirect.pizza
- IP address: 89.41.169.49
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "KLISBio"
Home | KLISBio
KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.See details»
KLISBio 2025 Company Profile: Valuation, Funding
KLISBio General Information Description. Developer of an innovative medical technology designed to find new tissue regeneration methods. The company's …See details»
KLISBio - Crunchbase Company Profile & Funding
Contact Email [email protected] KLISBio is challenging the status quo in regenerative medicine by leveraging silk as a powerful, scalable and biocompatible scaffold …See details»
KLISBio - 2025 Company Profile, Funding & Competitors - Tracxn
KLISBio - Developer of regenerative implantable products by using silk fibroins. Raised a total funding of $8.58M over 8 rounds from 9 investors. Founded by Gabriele Grecchi, Lorenzo Sala …See details»
KLISBio - LinkedIn
KLISBio is a clinical-stage regenerative medicine company. We are developing several innovative technology platforms based entirely on natural silk fibroin, which allow for the creation of various ...See details»
KLISBio Company Profile - Office Locations, Competitors ... - Craft
KLISBio has 5 employees at their 1 location and $8.88 m in total funding,. See insights on KLISBio including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
KLISBio
KLISBio Co-Founder & CEO, Gabriele Grecchi, presenting our Company at the MedTech Summit 2020 in Los Angeles, USA.See details»
KLISBio - Products, Competitors, Financials, Employees, …
About KLISBio. KLISBio is a med-tech company. The company develops regenerative implantable products by using silk fibroins. The company leverages a silk-based technology platform to …See details»
KLISBio – Funding, Valuation, Investors, News
Mar 18, 2025 KLISBio is a clinical-stage regenerative medicine company. We are developing several innovative technology platforms based entirely on natural silk fibroin, which allow for …See details»
About Us | KLISBio
Segnalazioni o testimonianze di comportamenti riconducibili a discriminazioni, molestie, abusi, violenze o mobbing possono essere effettuate compilando, anche in forma anonima, il modulo presente al seguente link, oppure …See details»
KLISBio - VentureRadar
Serum Bio-technology Unknown n/a Serum Biotech is a high-tech enterprise specialized in research, development, production and sales of antitoxin and antiserum products in China. …See details»
KLISBio - Funding, Financials, Valuation & Investors - Crunchbase
Silk-fibroin tissue engineering technology platformSee details»
Silk Biomaterials inaugura la prossima tappa evolutiva …
L’attività di KLISBio è focalizzata sullo sviluppo di soluzioni biomediche innovative che rispondono a esigenze cliniche rilevanti ancora non risolte, attraverso una piattaforma tecnologica …See details»
Contacts | KLISBio
[email protected]. REQUEST INFORMATION. suggest a new project Work with us Try our solutions Join upcoming events Create new and scientific evidences Receive company materials & …See details»
KLISBio on LinkedIn: #headquarters #health #openzone
We chose the Italian #headquarters of KLISBio to be in OpenZone, a campus dedicated to #health and based on an open, innovative approach, designed to create…See details»
KLISBio | VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
KLISBio | KLISBio
KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of …See details»
KLISBio | KLISBio
[email protected]. Unforeseen events, coincidence and intuition are often breeding ground of great ideas, but turning those ideas into reality and excellence requires commitment, expertise and a …See details»
KLISBio | KLISBio
KLIS (“silk” spelled backwards) and Bio represent the company’s commitment to utilizing the power of silk fibroin to promote an endogenous repair of human soft tissues. Both the …See details»
BIO Announces Dedicated Focus on Human Health and …
1 day ago Washington, DC, May 28, 2025 – The Biotechnology Innovation Organization (BIO) today announced plans to dedicate its focus entirely to human health and to transition the work …See details»